{"name":"Cadent Therapeutics","slug":"cadent-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBsRVE1X3dMcXNYZnFLd1c4Wmh5UzJ3Yk16NE9nbFgydk9manpyMkUtTzYxQlJTdkVmLVl5YXU4MFlPejRtQURGbzFMTXk1THVBUVNkaVBYWWpXS2t1RGhv?oc=5","date":"2025-04-23","type":"pipeline","source":"PharmaTimes","summary":"Noah Goodman - PharmaTimes","headline":"Noah Goodman","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQS3F3TURmVlZPb2xPQl9MVmZLV0JxWk1mTGpjcWtYaE5ad1phTDdKUzdLcjFUQjBPUU9JNXUzalhRVmxwa1pfSFV2aTkxOTU3UGZrQy1wSlc0QmJDUElLeG1NMkdWdzhGOVNVNnJUWHJNZEladnFWNGR4OTVXZVlTV1VZQ1BkMnVJNXU2cmRtOGpRYnFvZjl6aGFSVV9nc0RDY0dfb0M0VQ?oc=5","date":"2023-10-10","type":"trial","source":"Fierce Biotech","summary":"Novartis cuts depression study, nearly erasing $210M Cadent acquisition from pipeline - Fierce Biotech","headline":"Novartis cuts depression study, nearly erasing $210M Cadent acquisition from pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE92YmlKaTRMUDBpVkt6TU9KLVBIM3hjMTVZcUZiSnFpTkx6aV93LTNzYjVDYVVLYnNQZGUyTFh1LWctbGFEdG1ZQXF0MDNhM2FHNzhpVVZhaTRJZjI1dzFR?oc=5","date":"2022-02-01","type":"pipeline","source":"Nature","summary":"Edward F. Domino, Ph.D. (1924–2021) - Nature","headline":"Edward F. Domino, Ph.D. (1924–2021)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPeGliREJyQlZPaHFFbjhERWtsdzc5Um96aS0yQVFlVVMxR1llVkk1YkVtdW5TaEhKa0FGM1VGNWxmb2k0OFdMV1B0ZF9iWjBiTlpUakkwdkRFYUdNalBEX2pObUVtREYzZkNIM3ZVVlNUWGlkejhHVHZBWEZGcnQyaWV1MHp5WHJiOUt5cGdJdld1LVhES3NRNkFUdHlIS193X01hUG9Yc0FxT1J3eXdnbzZZY1E0alZYMEhnNWZTVFRobm5TNFBRQThSV0lJRGVwY3pnM205QURwc0kzOE5ySjU5Q0hTSmpaaE5pWEtUWUFDUQ?oc=5","date":"2021-06-11","type":"pipeline","source":"GlobeNewswire","summary":"Mental Disorder Drugs Market size worth US$58.91 Billion by 2031. Visiongain Research Inc. - GlobeNewswire","headline":"Mental Disorder Drugs Market size worth US$58.91 Billion by 2031. Visiongain Research Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5lOWtoOGQxZDEzX0lKMVc5Z3VPVVc1UHZGbE5XWkptOHRqTHV1NEIwYno4andHRFpoQVhMTXNXaEd2UW1RU1FVV3lQYUprMDZNOHRsSGh4a3ZMU2lXMlBqa21jMFc2MnRZcXR3ME9uTjhSTFpRTC1DX2pNMzA?oc=5","date":"2020-12-22","type":"deal","source":"JD Supra","summary":"Cadent Therapeutics Acquired by Novartis for Up to $770 Million - JD Supra","headline":"Cadent Therapeutics Acquired by Novartis for Up to $770 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQc0l4ZHRyTnZhTWVycmppbVRBR25EUVJKTmItbzFSOTJjOUN6cFRnLUh2QXR5WG5yQjlQSjZpSWt2RkxRRVVZR0MwZ3ZNM1pZTUZ3MmQzMnpvbS1DYXlPY2U0YlF3VHpmbEpBM2xLTDZNOU1FUFdBT1c5LWV4TUZCZ05KTTRBYjFkUXo4STNvQ1NiSmtGT2N5bU5yUk5qZnNUUmhyUE94SWF2NUhtTGdJbkUxOUVHLTdpWlNyQmw3WUp1cWZMeDBwWEYyak1waEpzdG5pcXpmcE12alJobDNv?oc=5","date":"2020-12-17","type":"pipeline","source":"Novartis","summary":"Novartis builds on commitment to addressing need in neuropsychiatric disorders with Cadent Therapeutics acquisition - Novartis","headline":"Novartis builds on commitment to addressing need in neuropsychiatric disorders with Cadent Therapeutics acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNTXpJQUdBRG5ZMGVwWXphWW9BU21XVDBWS2lIRGJWWXVydkR2YnhTdkhHTGpkS1BMMGpicURDbERFbG9aSFpTZlBuakJKUF9CUm1hSVpWMXJtYmpRV1dqVm56blZJSWc5dVRCLXJCUnBHTVRUUHFpRUpvMW1BUzl4QXhDSFF6RHVNZlptRHFKRmcxbTN4aWRsejNTWV96ZkxkMmZiQnN6eWI4WXBWU0QxUk1tVDRKb1hH?oc=5","date":"2020-12-17","type":"deal","source":"Fierce Biotech","summary":"Novartis snaps up neuro partner Cadent for $210M upfront with promise of up to $560M more - Fierce Biotech","headline":"Novartis snaps up neuro partner Cadent for $210M upfront with promise of up to $560M more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBDOVIzZjRwaFBZWS1tMnBNcm1NcHJqTVlSVGpZanI3OGZ5WjhxallWR1lDamNuZDJ0Sm1UMEdqeDkyYWtST1ZOV3hwa19PZlVWajJHMVhtdEYtZmZvZE0wVm9EUkpEUXgtOTRDUGlUdjJmcWtxM2lFZWIxQUVEV28?oc=5","date":"2020-12-17","type":"deal","source":"Pharmaceutical Technology","summary":"Novartis to acquire neuroscience firm Cadent Therapeutics for up to $770m - Pharmaceutical Technology","headline":"Novartis to acquire neuroscience firm Cadent Therapeutics for up to $770m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOLWtsUGZ4Sjc4QjVia2ExVFo1S2ZfVFd3RS1mNXVIWmNSdnpLVUlnc29DS3duUVQtR01kZzFsZE5TWDZaX0FIMWZQZUJqWWp5UFdJa3JKNFBUUS14bDhYbmhHMV9kaHpBRmJibEc1Sy1GYlFkZDJIVkpna1hXWU5aLVZOZUNPMHBRb2NDVGthZjZ3VUF4?oc=5","date":"2020-12-17","type":"deal","source":"BioPharma Dive","summary":"Novartis acquires a small biotech and its trio of brain drugs - BioPharma Dive","headline":"Novartis acquires a small biotech and its trio of brain drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNYi1FZlAxZDRBd0hNMFlSa0IzTFc3MTF4elFsV3YzQjdJUGRWcUJIS2NkZk4wRHBtakJBcTBpczFUREJOWV9hcWMzZDRiNkVhOFRrc2d4Wm1uV0RNS1ZVSUxTczZYSmFCMkZraGFBdXNyR3BqZEtCQjltaDMzRnlxLWVEUVduZzVtYWdj?oc=5","date":"2020-12-17","type":"deal","source":"pharmaphorum","summary":"Novartis buys neurology biotech Cadent for up to $770m - pharmaphorum","headline":"Novartis buys neurology biotech Cadent for up to $770m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQQ2NjZnNXck5iYWhiNmYzeGxYZ2w4MDFvbmlnRlFzVVQwSU5YYloweldFclFlQ2VqdGg1a2xIYkVHQ1hTMUZzNHFOOUtmZWRvdHYyX3BUWnlhRGhMVldGdGpZWFYzWUlfYmZzSWs2T0hoOXVadWNlZmJxOF8wdl9aNTNuTXlrLTF0QjdNZzVTQnlySThRaWJhNUNGVTBOTXpvel92MXBn?oc=5","date":"2018-11-15","type":"pipeline","source":"Fierce Biotech","summary":"Cadent Therapeutics bags $40M for neuro pipeline, Bob Dagher as CMO - Fierce Biotech","headline":"Cadent Therapeutics bags $40M for neuro pipeline, Bob Dagher as CMO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQX2lqM3hndHh6SmlQSUpmQ0JRUjdxTmppT0NlRDg4aWVhcUtTWVZ3emFqR19fc1M5VE5QbjdNRTMzaTE5WGM2dS1nMkJlaXdhUUQ1UWd3UVBjQ0xRNEhNc0tlMlJBajNwNHZPOTJzNThEMWFYUm5yMGdMa2JXTHJJNTJvSkd3RkJ2T3NyR0EwMTF4bnNPZWNfTFBrQTZCdUhmQ3IyQnV0MU1saVRIbGFGWmJVNlNsTEFJVmVFSmZMOXRCbzhOdUFTZ1FkSXpENUdzX3dEQmtuTzU?oc=5","date":"2017-10-17","type":"trial","source":"prnewswire.com","summary":"Cadent Therapeutics Receives Milestone for the Initiation of Phase 1 Clinical Studies - prnewswire.com","headline":"Cadent Therapeutics Receives Milestone for the Initiation of Phase 1 Clinical Studies","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}